Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
letter
. 1992 Nov;66(5):984–985. doi: 10.1038/bjc.1992.397

Sialyl Tn as a prognostic marker in epithelial ovarian cancer.

H Kobayashi, T Terao, Y Kawashima
PMCID: PMC1977998  PMID: 1419648

Full text

PDF
984

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bast R. C., Jr, Klug T. L., St John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13;309(15):883–887. doi: 10.1056/NEJM198310133091503. [DOI] [PubMed] [Google Scholar]
  2. Fukushi Y., Kannagi R., Hakomori S., Shepard T., Kulander B. G., Singer J. W. Location and distribution of difucoganglioside (VI3NeuAcV3III3Fuc2nLc6) in normal and tumor tissues defined by its monoclonal antibody FH6. Cancer Res. 1985 Aug;45(8):3711–3717. [PubMed] [Google Scholar]
  3. Itzkowitz S. H., Bloom E. J., Kokal W. A., Modin G., Hakomori S., Kim Y. S. Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer. 1990 Nov 1;66(9):1960–1966. doi: 10.1002/1097-0142(19901101)66:9<1960::aid-cncr2820660919>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  4. Kobayashi H., Terao T., Kawashima Y. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer. J Clin Oncol. 1991 Jun;9(6):983–987. doi: 10.1200/JCO.1991.9.6.983. [DOI] [PubMed] [Google Scholar]
  5. Niloff J. M., Knapp R. C., Lavin P. T., Malkasian G. D., Berek J. S., Mortel R., Whitney C., Zurawski V. R., Jr, Bast R. C., Jr The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer. Am J Obstet Gynecol. 1986 Jul;155(1):56–60. doi: 10.1016/0002-9378(86)90077-3. [DOI] [PubMed] [Google Scholar]
  6. Nozawa S., Yajima M., Kojima K., Iizuka R., Mochizuki H., Sugawara T., Iwamori M., Nagai Y. Tumor-associated mucin-type glycoprotein (CA54/61) defined by two monoclonal antibodies (MA54 and MA61) in ovarian cancers. Cancer Res. 1989 Jan 15;49(2):493–498. [PubMed] [Google Scholar]
  7. Zanaboni F., Vergadoro F., Presti M., Gallotti P., Lombardi F., Bolis G. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma. Gynecol Oncol. 1987 Sep;28(1):61–67. doi: 10.1016/s0090-8258(87)80009-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES